These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27310201)

  • 41. Patient-provider interaction, patient satisfaction, and health outcomes: testing explanatory models for people living with HIV/AIDS.
    Oetzel J; Wilcox B; Avila M; Hill R; Archiopoli A; Ginossar T
    AIDS Care; 2015; 27(8):972-8. PubMed ID: 25738878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
    Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
    AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targets for intervention to improve virological outcomes for patients receiving free antiretroviral therapy in Tamil Nadu, India.
    McMahon JH; Manoharan A; Wanke C; Mammen S; Jose H; Malini T; Kadavanu T; Jordan MR; Elliott JH; Lewin SR; Mathai D
    AIDS Care; 2014; 26(5):559-66. PubMed ID: 24125035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
    Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
    Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adherence to antiretroviral therapy and correlation with adverse effects and coinfections in people living with HIV/AIDS in the municipality of Goiás State.
    Oliveira LDS; Caixeta LM; Martins JLR; Segati KD; Moura RS; Daher MC; Pinto EMH
    Rev Soc Bras Med Trop; 2018; 51(4):436-444. PubMed ID: 30133625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating Measures of Pre-ART Adherence Readiness Through Associations with ART Adherence in the Early Months of Treatment.
    Azhar GS; Schneider S; Hoffman R; Gordon K; Ramirez D; Wagner G
    AIDS Behav; 2020 Feb; 24(2):648-654. PubMed ID: 31650358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self-reported adherence to antiretroviral therapy in HIV+ population from Bata, Equatorial Guinea.
    Salmanton-García J; Herrador Z; Ruiz-Seco P; Nzang-Esono J; Bendomo V; Bashmakovic E; Nseng-Nchama G; Benito A; Aparicio P
    AIDS Care; 2016; 28(5):543-53. PubMed ID: 26698540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.
    Dworkin MS; Douglas GW; Sabitha Rani GP; Chakraborty A
    Int J STD AIDS; 2016 Mar; 27(3):186-95. PubMed ID: 25801316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study.
    Medin G; García-Navarro C; Navarro Gomez M; Ramos Amador JT; Mellado MJ; Jimenez S; Muñoz-Fernández MA; Rojo Conejo P; Saavedra J; García Hortelano M; Guillén S; González-Tomé MI
    AIDS Care; 2016; 28(1):124-30. PubMed ID: 26307530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China.
    Da W; Li X; Qiao S; Zhou Y; Shen Z
    PLoS One; 2018; 13(8):e0203032. PubMed ID: 30161177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
    Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
    Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of the WebAd-Q Questionnaire to monitor adherence to HIV therapy.
    Vale FC; Santa-Helena ET; Santos MA; Carvalho WMDES; Menezes PR; Basso CR; Silva MH; Alves AM; Nemes MIB
    Rev Saude Publica; 2018; 52():62. PubMed ID: 29846437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychosocial Syndemics are Additively Associated with Worse ART Adherence in HIV-Infected Individuals.
    Blashill AJ; Bedoya CA; Mayer KH; O'Cleirigh C; Pinkston MM; Remmert JE; Mimiaga MJ; Safren SA
    AIDS Behav; 2015 Jun; 19(6):981-6. PubMed ID: 25331267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sexual satisfaction and its associations with patient-reported outcomes in a cohort of women living with human immunodeficiency virus in Sweden.
    Carlsson-Lalloo E; Berg M; Rusner M; Svedhem V; Mellgren Å
    Int J STD AIDS; 2022 Jul; 33(8):751-760. PubMed ID: 35622448
    [No Abstract]   [Full Text] [Related]  

  • 59. Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients.
    Bucciardini R; Pugliese K; Weimer L; Digregorio M; Fragola V; Mancini M; Maroccia Z; Ladisa N; Francisci D; Bellagamba R; Degli Antoni A; Guaraldi G; Cirioni O; Ortu F; Parruti G; Mannazzu M; Libertone R; Donnini S; Floridia M;
    HIV Clin Trials; 2014; 15(4):176-83. PubMed ID: 25143026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.